Renub

    Molecular Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Oct 2023
    Pages: 210

    Molecular Diagnostics Market Outlook

    Molecular Diagnostics Market size will reach US$ 28.17 Billion by 2030, according to Renub Research. To develop effective rapid diagnostics, developers are increasingly moving away from the classical methods requiring the culture of the pathogens and turning to scientific advances from various fields. One of the fastest-growing areas in infectious disease identification is molecular diagnostics, which includes techniques such as DNA (deoxyribonucleic acid) microarray analysis, mass spectrometry, and nucleic acid amplification.

    The global increase in the elderly population and the emergence of various diseases has fueled market growth. A surge in conditions such as cancer, cardiovascular diseases, neurological disorders, diabetes, and obesity, often linked to the ageing population, is propelling market expansion. In 2023, the National Institutes of Health projects approximately 1,958,310 cancer cases in the United States, intensifying the global demand for early diagnosis. Molecular diagnostics is pivotal in early cancer detection, enabling healthcare providers to initiate treatment before symptoms manifest and addressing cancer's significant global impact on morbidity and mortality. 


    Molecular Diagnostics Market will grow at a CAGR of 7.40% from 2023 to 2030

    The market is expected to experience significant growth due to the increasing incidence of infectious diseases during the forecast period. Notably, the rising prevalence of sexually transmitted infections (STIs) such as HIV and HPV is expanding the target population, contributing to market expansion. According to the India TB Report 2022, the number of reported incident TB cases in India increased from 1,628,161 in 2020 to 1,933,381 in 2021, indicating a growing patient pool and heightened demand for molecular diagnostics.

    Furthermore, individuals living with HIV are highly susceptible to other infections, particularly tuberculosis, which remains a leading cause of death among this population. Globally, the incidence of infectious diseases like HIV is on the rise, with approximately 38.4 million people worldwide diagnosed with HIV in 2021, as reported by UNAIDS in August 2022. This increased prevalence of infectious diseases is expected to drive Global Molecular Diagnostics Market growth as molecular diagnostics for HIV gain wider adoption.

    Market players' efforts to enhance access to cost-effective resources are anticipated to drive growth in the molecular diagnostics market. Molecular diagnostics tests offer precise and effective results, crucial in disease diagnostics. However, the relatively high costs associated with these tests have posed a challenge. Nevertheless, ongoing research and development efforts and technological advancements in molecular diagnostics are expected to fuel market expansion. Additionally, improvements in companion diagnostics and opportunities in emerging economies present significant growth prospects for companies operating in the molecular diagnostics market share. The molecular diagnostics market was valued at US$ 17.09 Billion in 2023.


    Reagents segment is poised to maintain its leading position in the foreseeable future

    Products segment the Molecular Diagnostic Market into Reagents& kits, Instruments and Software& Services. The reagents segment is well-positioned to uphold its top-ranking status in the molecular diagnostics market. This is attributed to ongoing advancements in research and development, especially in pharmaceuticals and biotechnology, which drive the demand for high-quality reagents. 

    Additionally, the critical role of reagents in facilitating precise and efficient molecular diagnostic tests ensures their continued prominence. As molecular diagnostics continues to expand in various applications, including disease diagnosis and genetic testing, the reliance on reagents as fundamental components is expected to solidify its leading position within this dynamic market.


    Oncology sector is expected to have a substantial CAGR in the molecular diagnostics market forecast

    By Application, Molecular Diagnostic Market is divided into Oncology, Infectious Disease, Genetic Testing, Blood Screening and Other Applications. The oncology sector is poised to claim a significant portion of the molecular diagnostics market. With a growing emphasis on early cancer detection and personalized treatment approaches, the demand for molecular diagnostics in oncology remains robust. This sector is pivotal in detecting specific genetic markers and mutations associated with various cancers, guiding treatment decisions, and monitoring disease progression. As the importance of precision medicine continues to rise, the oncology segment's substantial presence is expected to persist, reflecting its vital contribution to improving cancer diagnosis, prognosis, and treatment outcomes in the healthcare landscape.


    Polymerase chain reaction (PCR) segment held the highest revenue share

    By Technology, the Molecular Diagnostic Market is classified into Polymerase Chain Reaction, Hybridization, Isothermal Nucleic Amplification Technology (INAAT), Chips & Microarrays, DNA Sequencing and Others (Mass Spectrometry, TMA). The molecular diagnostics market is poised for significant expansion, driven by the increasing adoption of PCR technology for detecting a wide range of infectious and genetic diseases. 

    PCR's precision and sensitivity make it a crucial tool for diagnosing infectious diseases and genetic disorders. As healthcare providers and researchers increasingly rely on this Technology for accurate and timely diagnoses, its contribution to market growth becomes more pronounced. This trend underscores the pivotal role of PCR in advancing molecular diagnostics, ultimately benefiting patient care and disease management across diverse medical fields.


    Diagnostics Laboratories sector is expected to maintain its ongoing trajectory throughout the forecast period in the molecular diagnostics market

    By End User, the Molecular Diagnostic Market is sub-segmented into Hospitals & Clinics, Diagnostics Laboratories and Others. The Diagnostics Laboratories sector is projected to sustain its revenue share within the molecular diagnostics market. With a strong presence in the healthcare landscape, diagnostic laboratories are instrumental in conducting molecular diagnostic tests. These laboratories offer crucial services for accurate disease detection, personalized medicine, and genetic profiling. As the demand for molecular diagnostics grows across various medical disciplines, diagnostic laboratories remain pivotal players. Their ability to deliver precise and timely results is expected to ensure the sector's consistent contribution to the molecular diagnostics market, fostering advancements in patient care and medical research.


    China is expected to grow at the fastest rate during the forecast period

    By Countries, the Molecular Diagnostic Market is broken up into United States, Canada, Germany, United Kingdom, France, Italy, Spain, Switzerland, Japan, China, India, Australia, South Korea, Indonesia, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, United Arab Emirates, and Rest of World. China is poised for remarkable growth and is projected to achieve the highest compound annual growth rate during the forecast period within the molecular diagnostics market. 

    This surge in demand is fueled by several factors, including a burgeoning population, increasing healthcare infrastructure, and rising awareness of the importance of early disease detection. Additionally, government initiatives and investments in healthcare and biotechnology further propel the adoption of molecular diagnostics in the country. As China advances in medical research and technology, its robust CAGR underscores its potential to become a significant player in the global molecular diagnostics landscape.


    Key Player

    Abbott Laboratories, Myriad Genetics, Roche Diagnostics, BioMerieux SA, Danaher Corporation, Qiagen NV, Bio-rad Laboratories Inc., and Hologic (Gen-Probe) are prominent players in the molecular diagnostics market.


    Renub Research latest report “Molecular Diagnostics Market, Global Forecast By Product (Reagents& Kits, Instruments and Software & Services), Application (Oncology, Infectious Disease, Genetic Testing, Blood Screening and Other Applications), Technology (Polymerase Chain Reaction, Hybridization, Isothermal Nucleic Amplification Technology (INAAT), Chips & Microarrays, DNA Sequencing and Others (Mass Spectrometry, TMA), End User (Hospitals & Clinics, Diagnostics Laboratories and Others), Region (North America (United States, Canada), Europe (Germany, the United Kingdom, France, Italy, Spain, Switzerland), Asia Pacific (Japan, China, India, Australia, South Korea, Indonesia), South America (Brazil, Argentina, Mexico), Middle East and Africa (South Africa, Saudi Arabia, the United Arab Emirates) & Rest of the World), Company Analysis (Abbott Laboratories, Myriad Genetics, Roche Diagnostics, BioMerieux SA, Danaher Corporation, Qiagen NV, Bio-rad Laboratories Inc., and Hologic (Gen-Probe))” provides a detailed analysis of Global Molecular Diagnostic Industry.


    Product - Market we have covered the market from 3 viewpoints:

    1.    Reagents & kits
    2.    Instruments
    3.    Software & Services


    Application - Market we have covered the market from 5 viewpoints:

    1.    Oncology 
    2.    Infectious Disease
    3.    Genetic Testing 
    4.    Blood Screening 
    5.    Other Applications


    Technology - Market we have covered the market from 6 viewpoints:

    1.    Polymerase Chain Reaction 
    2.    Hybridization
    3.    Isothermal Nucleic Amplification Technology (INAAT)
    4.    Chips & Microarrays
    5.    DNA Sequencing
    6.    Others (Mass Spectrometry, TMA)


    End User - Market we have covered the market from 3 viewpoints:

    1.    Hospitals & Clinics
    2.    Diagnostics Laboratories
    3.    Others


    Country – Country – This report covers the 21 Countries Molecular Diagnostics Market

    1.    North America

    1.1    United States
    1.2    Canada

    2.    Europe

    2.1    Germany
    2.2    United Kingdom
    2.3    France
    2.4    Italy
    2.5    Spain
    2.6    Switzerland

    3.    Asia Pacific

    3.1    Japan
    3.2    China
    3.3    India
    3.4    Australia
    3.5    South Korea
    3.6    Indonesia

    4.    Latin America

    4.1    Brazil
    4.2    Argentina
    4.3    Mexico

    5.    Middle East and Africa

    5.1    South Africa
    5.2    Saudi Arabia
    5.3    United Arab Emirates

    6.    Rest of World


    Company Insights:

    •    Overview
    •    Recent Development
    •    Revenue


    Company Analysis:

    1.    Abbott Laboratories
    2.    Myriad Genetics
    3.    Roche Diagnostics
    4.    BioMerieux SA
    5.    Danaher Corporation
    6.    Qiagen NV
    7.    Bio-rad Laboratories Inc
    8.    Hologic (Gen-Probe)

     

    Report Details:

    Report Features Details
    Base Year 2023
    Historical Period 2017 - 2023
    Forecast Period 2024 - 2030
    Market US$ Billion
    Segment Covered Product, Application, Technology, End User, Countries
    Region Covered United States, Canada, Germany, United Kingdom, France, Italy, Spain, Switzerland, Japan, China, India, Australia, South Korea, Indonesia, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, United Arab Emirates, and Rest of World
    Companies Covered AAbbott Laboratories, Myriad Genetics, Roche Diagnostics, BioMerieux SA, Danaher Corporation, Qiagen NV, Bio-rad Laboratories Inc., and Hologic (Gen-Probe)
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

    1.    Introduction

    2.    Research Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Global Molecular Diagnostic Market

    6.    Market Share – Global Molecular Diagnostic Market

    6.1    By Products
    6.2    By Application
    6.3    By Technology
    6.4    By End User
    6.5    By Countries


    7.    Product – Global Molecular Diagnostic Market

    7.1    Reagents & kits
    7.2    Instruments
    7.3    Software & Services


    8.    Application – Global Molecular Diagnostic Market

    8.1    Oncology
    8.2    Infectious Disease
    8.3    Genetic Testing
    8.4    Blood Screening
    8.5    Other Applications


    9.    Technology – Global Molecular Diagnostic Market

    9.1    Polymerase Chain Reaction
    9.2    Hybridization
    9.3    Isothermal Nucleic Amplification Thechnology (INAAT)
    9.4    Chips & Microarrays
    9.5    DNA Sequencing
    9.6    Others (Mass Spectrometry, TMA)


    10.    End User – Global Molecular Diagnostic Market

    10.1    Hospitals & Clinics
    10.2    Diagnostics Laboratories
    10.3    Others


    11.    Countries – Global Molecular Diagnostic Market

    11.1    North America

    11.1.1    United States
    11.1.2    Canada

    11.2    Europe

    11.2.1    Germany
    11.2.2    United Kingdom
    11.2.3    France
    11.2.4    Italy
    11.2.5    Spain
    11.2.6    Switzerland

    11.3    Asia Pacific

    11.3.1    Japan
    11.3.2    China
    11.3.3    India
    11.3.4    Australia
    11.3.5    South Korea
    11.3.6    Indonesia

    11.4    Latin America

    11.4.1    Brazil
    11.4.2    Argentina
    11.4.3    Mexico

    11.5    Middle East and Africa

    11.5.1    South Africa
    11.5.2    Saudi Arabia
    11.5.3    United Arab Emirates

    11.6    Rest of World


    12.    Porter’s Five Forces Analysis – Global Molecular Diagnostic Market

    12.1    Bargaining Power of Buyers
    12.2    Bargaining Power of Suppliers
    12.3    Degree of Rivalry
    12.4    Threat of New Entrants
    12.5    Threat of Substitutes


    13.    SWOT Analysis – Global Molecular Diagnostic Market

    13.1    Strength
    13.2    Weakness
    13.3    Opportunity
    13.4    Threat


    14.    Company Analysis

    14.1    Abbott Laboratories

    14.1.1    Overview
    14.1.2    Recent Development
    14.1.3    Revenue

    14.2    Myriad Genetics

    14.2.1    Overview
    14.2.2    Recent Development
    14.2.3    Revenue

    14.3    Roche Diagnostic

    14.3.1    Overview
    14.3.2    Recent Development
    14.3.3    Revenue

    14.4    BioMerieux SA

    14.4.1    Overview
    14.4.2    Recent Development
    14.4.3    Revenue

    14.5    Danaher Corporation

    14.5.1    Overview
    14.5.2    Recent Development
    14.5.3    Revenue

    14.6    Qiagen NV

    14.6.1    Overview
    14.6.2    Recent Development
    14.6.3    Revenue

    14.7    Bio rad laboratories, inc

    14.7.1    Overview
    14.7.2    Recent Development
    14.7.3    Revenue

    14.8    Hologic (Gen Probe)

    14.8.1    Overview
    14.8.2    Recent Development
    14.8.3    Revenue


    List of Figures:

    Figure-01:    Global – Molecular Diagnostic Market (Billion US$), 2018 – 2023
    Figure-02:    Global – Forecast for Molecular Diagnostic Market (Billion US$), 2024 – 2030
    Figure-03:    Product – Reagents & kits Market (Million US$), 2018 – 2023
    Figure-04:    Product – Forecast for Reagents & kits Market (Million US$), 2024 – 2030
    Figure-05:    Product – Instruments Market (Million US$), 2018 – 2023
    Figure-06:    Product – Forecast for Instruments Market (Million US$), 2024 – 2030
    Figure-07:    Product – Software & Services Market (Million US$), 2018 – 2023
    Figure-08:    Product – Forecast for Software & Services Market (Million US$), 2024 – 2030
    Figure-09:    Application – Oncology Market (Million US$), 2018 – 2023
    Figure-10:    Application – Forecast for Oncology Market (Million US$), 2024 – 2030
    Figure-11:    Application – Infectious Disease Market (Million US$), 2018 – 2023
    Figure-12:    Application – Forecast for Infectious Disease Market (Million US$), 2024 – 2030
    Figure-13:    Application – Genetic Testing Market (Million US$), 2018 – 2023
    Figure-14:    Application – Forecast for Genetic Testing Market (Million US$), 2024 – 2030
    Figure-15:    Application – Blood Screening Market (Million US$), 2018 – 2023
    Figure-16:    Application – Forecast for Blood Screening Market (Million US$), 2024 – 2030
    Figure-17:    Application – Other Applications Market (Million US$), 2018 – 2023
    Figure-18:    Application – Forecast for Other Applications Market (Million US$), 2024 – 2030
    Figure-19:    Technology – Polymerase Chain Reaction Market (Million US$), 2018 – 2023
    Figure-20:    Technology – Forecast for Polymerase Chain Reaction Market (Million US$), 2024 – 2030
    Figure-21:    Technology – Hybridization Market (Million US$), 2018 – 2023
    Figure-22:    Technology – Forecast for Hybridization Market (Million US$), 2024 – 2030
    Figure-23:    Technology – Isothermal Nucleic Amplification Thechnology (INAAT) Market (Million US$), 2018 – 2023
    Figure-24:    Technology – Forecast for Isothermal Nucleic Amplification Thechnology (INAAT) Market (Million US$), 2024 – 2030
    Figure-25:    Technology – Chips & Microarrays Market (Million US$), 2018 – 2023
    Figure-26:    Technology – Forecast for Chips & Microarrays Market (Million US$), 2024 – 2030
    Figure-27:    Technology – DNA Sequencing Market (Million US$), 2018 – 2023
    Figure-28:    Technology – Forecast for DNA Sequencing Market (Million US$), 2024 – 2030
    Figure-29:    Technology – Others (Mass Spectrometry, TMA) Market (Million US$), 2018 – 2023
    Figure-30:    Technology – Forecast for Others (Mass Spectrometry, TMA) Market (Million US$), 2024 – 2030
    Figure-31:    End User – Hospitals & Clinics Market (Million US$), 2018 – 2023
    Figure-32:    End User – Forecast for Hospitals & Clinics Market (Million US$), 2024 – 2030
    Figure-33:    End User – Diagnostics Laboratories Market (Million US$), 2018 – 2023
    Figure-34:    End User – Forecast for Diagnostics Laboratories Market (Million US$), 2024 – 2030
    Figure-35:    End User – Others Market (Million US$), 2018 – 2023
    Figure-36:    End User – Forecast for Others Market (Million US$), 2024 – 2030
    Figure-37:    United States – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-38:    United States – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-39:    Canada – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-40:    Canada – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-41:    Germany – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-42:    Germany – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-43:    United Kingdom – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-44:    United Kingdom – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-45:    France – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-46:    France – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-47:    Italy – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-48:    Italy – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-49:    Spain – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-50:    Spain – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-51:    Switzerland – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-52:    Switzerland – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-53:    Japan – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-54:    Japan – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-55:    China – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-56:    China – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-57:    India – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-58:    India – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-59:    Australia – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-60:    Australia – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-61:    South Korea – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-62:    South Korea – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-63:    Indonesia – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-64:    Indonesia – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-65:    Brazil – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-66:    Brazil – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-67:    Argentina – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-68:    Argentina – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-69:    Mexico – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-70:    Mexico – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-71:    South Africa – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-72:    South Africa – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-73:    Saudi Arabia – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-74:    Saudi Arabia – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-75:    United Arab Emirates – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-76:    United Arab Emirates – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-77:    Rest of World – Molecular Diagnostic Market (Million US$), 2018 – 2023
    Figure-78:    Rest of World – Forecast for Molecular Diagnostic Market (Million US$), 2024 – 2030
    Figure-79:    Abbott Laboratories – Global Revenue (Million US$), 2018 – 2023
    Figure-80:    Abbott Laboratories – Forecast for Global Revenue (Million US$), 2024 – 2030
    Figure-81:    Myriad Genetics – Global Revenue (Million US$), 2018 – 2023
    Figure-82:    Myriad Genetics – Forecast for Global Revenue (Million US$), 2024 – 2030
    Figure-83:    Roche Diagnostic – Global Revenue (Million US$), 2018 – 2023
    Figure-84:    Roche Diagnostic – Forecast for Global Revenue (Million US$), 2024 – 2030
    Figure-85:    BioMerieux SA – Global Revenue (Million US$), 2018 – 2023
    Figure-86:    BioMerieux SA – Forecast for Global Revenue (Million US$), 2024 – 2030
    Figure-87:    Danaher Corporation – Global Revenue (Million US$), 2018 – 2023
    Figure-88:    Danaher Corporation – Forecast for Global Revenue (Million US$), 2024 – 2030
    Figure-89:    Qiagen NV – Global Revenue (Million US$), 2018 – 2023
    Figure-90:    Qiagen NV – Forecast for Global Revenue (Million US$), 2024 – 2030
    Figure-91:    Bio rad laboratories, inc – Global Revenue (Million US$), 2018 – 2023
    Figure-92:    Bio rad laboratories, inc – Forecast for Global Revenue (Million US$), 2024 – 2030
    Figure-93:    Hologic (Gen Probe) – Global Revenue (Million US$), 2018 – 2023
    Figure-94:    Hologic (Gen Probe) – Forecast for Global Revenue (Million US$), 2024 – 2030


    List of Tables:

    Table-01:    Global – Molecular Diagnostic Market Share by Product (Percent), 2018 – 2023
    Table-02:    Global – Forecast for Molecular Diagnostic Market Share by Product (Percent), 2023 – 2030
    Table-03:    Global – Molecular Diagnostic Market Share by Application (Percent), 2018 – 2023
    Table-04:    Global – Forecast for Molecular Diagnostic Market Share by Application (Percent), 2023 – 2030
    Table-05:    Global – Molecular Diagnostic Market Share by Technology (Percent), 2018 – 2023
    Table-06:    Global – Forecast for Molecular Diagnostic Market Share by Technology (Percent), 2023 – 2030
    Table-07:    Global – Molecular Diagnostic Market Share by End User (Percent), 2018 – 2023
    Table-08:    Global – Forecast for Molecular Diagnostic Market Share by End User (Percent), 2023 – 2030
    Table-09:    Global – Molecular Diagnostic Market Share by Countries (Percent), 2018 – 2023
    Table-10:    Global – Forecast for Molecular Diagnostic Market Share by Countries (Percent), 2023 – 2030

    Related Reports